These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Imaging the ovine heparin-protamine interaction with 111In-protamine. Montalescot G; Fischman AJ; Strauss HW; Wilkinson RA; Ahmad M; Fitzgibbon C; Robinson DW; Zapol WM J Appl Physiol (1985); 1993 Aug; 75(2):963-71. PubMed ID: 8226502 [TBL] [Abstract][Full Text] [Related]
11. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741. Schumacher WA; Heran CL; Ogletree ML Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979 [TBL] [Abstract][Full Text] [Related]
12. Heparin-protamine complexes cause pulmonary hypertension in goats. Horiguchi T; Enzan K; Mitsuhata H; Murata M; Suzuki M Anesthesiology; 1995 Oct; 83(4):786-91. PubMed ID: 7574058 [TBL] [Abstract][Full Text] [Related]
13. C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin. Morel DR; Zapol WM; Thomas SJ; Kitain EM; Robinson DR; Moss J; Chenoweth DE; Lowenstein E Anesthesiology; 1987 May; 66(5):597-604. PubMed ID: 3495208 [TBL] [Abstract][Full Text] [Related]
14. Effect of leukopenia on pulmonary hypertension after heparin-protamine in pigs. Habazettl H; Conzen PF; Vollmar B; Yekebas E; Peter K J Appl Physiol (1985); 1992 Jul; 73(1):44-9. PubMed ID: 1506397 [TBL] [Abstract][Full Text] [Related]
15. Protamine-induced pulmonary venoconstriction in heparinized pigs. Hakim TS; Picone A; Oleary CE; Camporesi EM Anesth Analg; 1995 Jul; 81(1):38-43. PubMed ID: 7598279 [TBL] [Abstract][Full Text] [Related]
16. [Cellular mechanisms of pulmonary vasoconstriction in an experimental model of protamine reversal of heparin]. Montalescot G Arch Mal Coeur Vaiss; 1990 Apr; 83(4):555-60. PubMed ID: 2111678 [TBL] [Abstract][Full Text] [Related]
17. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation. Nuttall GA; Murray MJ; Bowie EJ Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertensive effect of heparin and protamine interaction: evidence for thromboxane B2 release from the lung. Degges RD; Foster ME; Dang AQ; Read RC Am J Surg; 1987 Dec; 154(6):696-9. PubMed ID: 3425821 [TBL] [Abstract][Full Text] [Related]
19. The heparin-protamine interaction. A review. Carr JA; Silverman N J Cardiovasc Surg (Torino); 1999 Oct; 40(5):659-66. PubMed ID: 10596998 [TBL] [Abstract][Full Text] [Related]
20. Absence of prostaglandin changes associated with protamine administration in patients with pulmonary hypertension. Konstadt SN; Thys DM; Kong D; Mindich BP; Watkins WD J Cardiothorac Anesth; 1987 Oct; 1(5):388-91. PubMed ID: 2979108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]